Impeto Medical is a French start-up company. It has developed an innovative procedure for the early diagnosis of diabetes. The product, which is called EzScan, fulfils a strong demand for improving the detection of diabetes.  This is a condition which is growing exponentially around the world and the longer it goes without being detected, the more severe are the consequences.

The launch of the product on the market was supported by an ambitious program of clinical studies. Contrary to normal practice for French start-up companies, Impeto Medical primarily targets international markets and wanted to set itself up right from the start with a comprehensive marketing and PR platform, which could be used worldwide.  In order to achieve this, Impeto Medical put its trust in the experience of bb&b’s founders in medical & scientific marketing and international markets. bb&b manages all of Impeto Medical's marketing business, including the creation of a visual identity, stands, publishing, Internet, multimedia etc.